DSM-Firmenich AG (DSFIY)

OTCMKTS · Delayed Price · Currency is USD
11.17
+0.08 (0.72%)
Nov 22, 2024, 4:00 PM EST
-5.50%
Market Cap 29.58B
Revenue (ttm) 13.35B
Net Income (ttm) -201.44M
Shares Out n/a
EPS (ttm) -0.76
PE Ratio n/a
Forward PE n/a
Dividend 0.22 (2.00%)
Ex-Dividend Date May 9, 2024
Volume 167,100
Open 11.24
Previous Close 11.09
Day's Range 10.96 - 11.30
52-Week Range 10.41 - 13.98
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 13, 2025

About DSM-Firmenich AG

DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]

Sector Materials
Founded 1902
Employees 28,685
Stock Exchange OTCMKTS
Ticker Symbol DSFIY
Full Company Profile

Financial Performance

In 2023, DSM-Firmenich AG's revenue was 10.63 billion, an increase of 26.66% compared to the previous year's 8.39 billion. Earnings were 2.13 billion, an increase of 25.80%.

Financial numbers in EUR Financial Statements

News

DSM-Firmenich AG (KDSKF) Q3 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q3 2024 Earnings Conference Call October 31, 2024 4:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ral...

23 days ago - Seeking Alpha

dsm-firmenich to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on September 25 2024

Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event Company invites individual and institutional investors, as well as advisors,...

2 months ago - GlobeNewsWire

DSM-Firmenich AG (KDSKF) Q2 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q2 2024 Earnings Conference Call July 30, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Dimitri de Vreeze - Chief Executive Officer Ralf S...

4 months ago - Seeking Alpha

DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Call Transcript

DSM-Firmenich AG (OTC:KDSKF) Q1 2024 Earnings Conference Call May 2, 2024 3:00 AM ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference C...

7 months ago - Seeking Alpha